TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Efficacy of Intravenous Paracetamol and Dexketoprofen for Acute Traumatic Musculoskeletal Pain in the Emergency Department: A Double-Blinded, Randomized, Controlled Trial
Brief Summary: * Currently, paracetamol and nonsteroidal antiinflammatory drugs are widely used by emergency physicians in Turkey for the treatment of patients with acute traumatic musculoskeletal pain.
* The objective of the study is compare the efficacy of intravenous dexketoprofen with paracetamol in the treatment of acute traumatic musculoskeletal pain.


Options:
A: Arm Label: Oxycodone/acetaminophen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxycodone/acetaminophen | Arm Label: Hydrocodone/acetaminophen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Hydrocodone/acetaminophen | Arm Label: Codeine/acetaminophen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Codeine/acetaminophen | Arm Label: Ibuprofen/acetaminophen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ibuprofen/acetaminophen | Intervention Type: DRUG; Name: Oxycodone/acetaminophen; Assigned to Arm(s): Oxycodone/acetaminophen | Intervention Type: DRUG; Name: Hydrocodone/acetaminophen; Assigned to Arm(s): Hydrocodone/acetaminophen | Intervention Type: DRUG; Name: Codeine/acetaminophen; Assigned to Arm(s): Codeine/acetaminophen | Intervention Type: DRUG; Name: Ibuprofen/acetaminophen; Assigned to Arm(s): Ibuprofen/acetaminophen
B: Arm Label: oral morphine and oral ibuprofen; Type: EXPERIMENTAL; Interventions: Drug: oral morphine and oral ibuprofen | Arm Label: morphine and placebo of ibuprofen; Type: EXPERIMENTAL; Interventions: Drug: Oral morphine | Arm Label: ibuprofen and placebo of morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oral ibuprofen | Intervention Type: DRUG; Name: oral morphine and oral ibuprofen; Assigned to Arm(s): oral morphine and oral ibuprofen | Intervention Type: DRUG; Name: Oral morphine; Assigned to Arm(s): morphine and placebo of ibuprofen | Intervention Type: DRUG; Name: Oral ibuprofen; Assigned to Arm(s): ibuprofen and placebo of morphine
C: Arm Label: Paracetamol; Type: EXPERIMENTAL; Interventions: Drug: Paracetamol | Arm Label: Dexketoprofen; Type: EXPERIMENTAL; Interventions: Drug: Dexketoprofen | Intervention Type: DRUG; Name: Paracetamol; Assigned to Arm(s): Paracetamol | Intervention Type: DRUG; Name: Dexketoprofen; Assigned to Arm(s): Dexketoprofen
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Paracetamol, Drug: Ibuprofen placebo | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Ibuprofen, Drug: Paracetamol Placebo | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Paracetamol, Drug: Ibuprofen | Intervention Type: DRUG; Name: Paracetamol; Assigned to Arm(s): 1, 3 | Intervention Type: DRUG; Name: Ibuprofen; Assigned to Arm(s): 2, 3 | Intervention Type: DRUG; Name: Paracetamol Placebo; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Ibuprofen placebo; Assigned to Arm(s): 1

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Decrease in Sympathetic Tone in OSA Patients: Is CPAP More Effective Than APAP ?
Brief Summary: The present study aims to compare muscle sympathetic neural activity by microneurography after one month treatment of fixed versus auto-adjusting CPAP treatment and its impact on arterial blood pressure


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: constant CPAP devices | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Device: automatic CPAP devices | Intervention Type: DEVICE; Name: constant CPAP devices; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: automatic CPAP devices; Assigned to Arm(s): 2
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: BiPap auto with Fi Flex | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard CPAP | Intervention Type: DEVICE; Name: BiPap auto with Fi Flex; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: Standard CPAP; Assigned to Arm(s): 2
C: Arm Label: Auto Aflex; Type: ACTIVE_COMPARATOR; Interventions: Device: Auto AFlex | Arm Label: Auto CPAP; Type: ACTIVE_COMPARATOR; Interventions: Device: Auto CPAP | Arm Label: CPAP; Type: ACTIVE_COMPARATOR; Interventions: Device: CPAP | Intervention Type: DEVICE; Name: Auto AFlex; Assigned to Arm(s): Auto Aflex | Intervention Type: DEVICE; Name: Auto CPAP; Assigned to Arm(s): Auto CPAP | Intervention Type: DEVICE; Name: CPAP; Assigned to Arm(s): CPAP
D: Arm Label: Fixed CPAP; Type: EXPERIMENTAL; Interventions: Device: Fixed CPAP | Arm Label: Auto-adjusting CPAP; Type: ACTIVE_COMPARATOR; Interventions: Device: Auto-adjusting CPAP | Intervention Type: DEVICE; Name: Fixed CPAP; Assigned to Arm(s): Fixed CPAP | Intervention Type: DEVICE; Name: Auto-adjusting CPAP; Assigned to Arm(s): Auto-adjusting CPAP

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effectiveness of Intracytoplasmic Sperm Injection Versus Conventional in Vitro Fertilization in Couples With Non-male Factor Infertility: a Randomized Controlled Trial
Brief Summary: Conventionally, ICSI was initially developed and has been shown to be an effective treatment for male factor infertility. It is increasingly being used for patients without a male factor diagnosis, despite the lack of clinical evidence to support its use. Moreover, ICSI is an invasive and expensive procedure. This multi-center, randomized, controlled, parallel-group trial will be conducted to compare the effectiveness of ICSI versus conventional IVF in infertile couples scheduled for IVF treatment, in whom the male partner has normal sperm.


Options:
A: Arm Label: IVF combined with PGT-A; Type: N/A; Interventions: Diagnostic Test: IVF combined with PGT-A | Arm Label: ICSI combined with PGT-A; Type: N/A; Interventions: Diagnostic Test: ICSI combined with PGT-A | Intervention Type: DIAGNOSTIC_TEST; Name: IVF combined with PGT-A; Assigned to Arm(s): IVF combined with PGT-A | Intervention Type: DIAGNOSTIC_TEST; Name: ICSI combined with PGT-A; Assigned to Arm(s): ICSI combined with PGT-A
B: Arm Label: Standard in vitro fertilisation (IVF); Type: ACTIVE_COMPARATOR; Interventions: Procedure: IVF | Arm Label: Intracytoplasmic sperm injection (ICSI); Type: ACTIVE_COMPARATOR; Interventions: Procedure: ICSI | Intervention Type: PROCEDURE; Name: IVF; Assigned to Arm(s): Standard in vitro fertilisation (IVF) | Intervention Type: PROCEDURE; Name: ICSI; Assigned to Arm(s): Intracytoplasmic sperm injection (ICSI)
C: Arm Label: Intracytoplasmic Sperm Injection; Type: ACTIVE_COMPARATOR; Interventions: Other: ICSI | Arm Label: Conventional IVF; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional IVF | Intervention Type: OTHER; Name: ICSI; Assigned to Arm(s): Intracytoplasmic Sperm Injection | Intervention Type: OTHER; Name: Conventional IVF; Assigned to Arm(s): Conventional IVF
D: Arm Label: Intracytoplasmic Sperm Injection (ICSI); Type: ACTIVE_COMPARATOR; Interventions: Procedure: ICSI | Arm Label: In Vitro Fertilization (IVF); Type: ACTIVE_COMPARATOR; Interventions: Procedure: IVF | Intervention Type: PROCEDURE; Name: ICSI; Assigned to Arm(s): Intracytoplasmic Sperm Injection (ICSI) | Intervention Type: PROCEDURE; Name: IVF; Assigned to Arm(s): In Vitro Fertilization (IVF)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Connecting Women to Care: Home-based Psychotherapy for Women With MST Living in Rural Areas
Brief Summary: Military sexual trauma (MST) is a common duty-related stressor which occurs among one in four female Veterans and is associated with substantial concerns about social isolation and high rates of PTSD. Women with MST also experience numerous person-level barriers to care including the desire to avoid male-dominated VA clinics, transportation difficulties and childcare responsibilities. Treatment programs that address the social and mental health needs of this population and acknowledge barriers to care that disproportionately affect women are lacking. The proposed study will use a hybrid effectiveness-implementation design to evaluate the in-home delivery of a gender-sensitive, evidence-based coping skills program to improve social and role functioning as well as reduce PTSD and will prioritize enrolling rural women in a representative manner. If the program is found to be successful at improving social functioning and PTSD, and in reducing barriers to care, it will provide a tremendous benefit to women Veterans with MST, particularly those in rural areas.


Options:
A: Arm Label: STAIR stands for Skills Training in Affective and Interpersonal Regulation; Type: EXPERIMENTAL; Interventions: Behavioral: Skills Training in Affective and Interpersonal Regulation | Arm Label: Present Centered Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Present Centered Therapy | Intervention Type: BEHAVIORAL; Name: Skills Training in Affective and Interpersonal Regulation; Assigned to Arm(s): STAIR stands for Skills Training in Affective and Interpersonal Regulation | Intervention Type: BEHAVIORAL; Name: Present Centered Therapy; Assigned to Arm(s): Present Centered Therapy
B: Arm Label: Eye Movement Desensitization Reprocessing (EMDR); Type: EXPERIMENTAL; Interventions: Behavioral: Eye Movement Desensitization Reprocessing (EMDR) | Intervention Type: BEHAVIORAL; Name: Eye Movement Desensitization Reprocessing (EMDR); Assigned to Arm(s): Eye Movement Desensitization Reprocessing (EMDR)
C: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Present-Centered Therapy | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): Arm 1 | Intervention Type: BEHAVIORAL; Name: Present-Centered Therapy; Assigned to Arm(s): Arm 2
D: Arm Label: Safety and Health Experiences Program; Type: EXPERIMENTAL; Interventions: Behavioral: SHE | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SHE; Assigned to Arm(s): Safety and Health Experiences Program

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Connecting Women to Care: Home-based Psychotherapy for Women With MST Living in Rural Areas
Brief Summary: Military sexual trauma (MST) is a common duty-related stressor which occurs among one in four female Veterans and is associated with substantial concerns about social isolation and high rates of PTSD. Women with MST also experience numerous person-level barriers to care including the desire to avoid male-dominated VA clinics, transportation difficulties and childcare responsibilities. Treatment programs that address the social and mental health needs of this population and acknowledge barriers to care that disproportionately affect women are lacking. The proposed study will use a hybrid effectiveness-implementation design to evaluate the in-home delivery of a gender-sensitive, evidence-based coping skills program to improve social and role functioning as well as reduce PTSD and will prioritize enrolling rural women in a representative manner. If the program is found to be successful at improving social functioning and PTSD, and in reducing barriers to care, it will provide a tremendous benefit to women Veterans with MST, particularly those in rural areas.


Options:
A: Arm Label: Qigong training; Type: EXPERIMENTAL; Interventions: Behavioral: Qigong training | Arm Label: Wait-list control- Health talks; Type: OTHER; Interventions: Other: Wait-list control- Health talks | Intervention Type: BEHAVIORAL; Name: Qigong training; Assigned to Arm(s): Qigong training | Intervention Type: OTHER; Name: Wait-list control- Health talks; Assigned to Arm(s): Wait-list control- Health talks
B: Arm Label: STAIR stands for Skills Training in Affective and Interpersonal Regulation; Type: EXPERIMENTAL; Interventions: Behavioral: Skills Training in Affective and Interpersonal Regulation | Arm Label: Present Centered Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Present Centered Therapy | Intervention Type: BEHAVIORAL; Name: Skills Training in Affective and Interpersonal Regulation; Assigned to Arm(s): STAIR stands for Skills Training in Affective and Interpersonal Regulation | Intervention Type: BEHAVIORAL; Name: Present Centered Therapy; Assigned to Arm(s): Present Centered Therapy
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Processing Therapy | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy, Behavioral: Hypnosis | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: Hypnosis; Assigned to Arm(s): 2
D: Arm Label: Brief Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Enhancement Therapy | Arm Label: Assessed Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: No Contact Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivational Enhancement Therapy; Assigned to Arm(s): Brief Intervention Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparative Effectiveness Research of Rehabilitation Methods and Prevention of Refracture After Fractures in Elderly Patients
Brief Summary: A number of studies for clinical pathway (CP) after hip fracture have been suggested to improve post-fracture outcome. However, CP is not carried out properly in most countries due to inadequate system and awareness, and lack of interdisciplinary approach among orthopaedists, geriatricians and rehabilitation specialists. Thus, we developed Fragility fracture integrated rehabilitation management (FIRM), a new standardized guideline and the multidisciplinary fragility fracture care based on the clinical rehabilitation pathway and conducted a prospective study to evaluate the effects of FIRM compared to conventional rehabilitation.


Options:
A: Arm Label: Care pathway teams.; Type: EXPERIMENTAL; Interventions: Behavioral: Care pathway. | Arm Label: Usual care teams.; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Care pathway.; Assigned to Arm(s): Care pathway teams.
B: Arm Label: Functional training group; Type: EXPERIMENTAL; Interventions: Other: Functional training program | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Functional training program; Assigned to Arm(s): Functional training group
C: Arm Label: FIRM group; Type: EXPERIMENTAL; Interventions: Other: FIRM | Arm Label: Conventional group; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional rehabilitation | Arm Label: No-rehabilitation group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: FIRM; Assigned to Arm(s): FIRM group | Intervention Type: OTHER; Name: Conventional rehabilitation; Assigned to Arm(s): Conventional group
D: Arm Label: Enhanced collaboration; Type: ACTIVE_COMPARATOR; Interventions: Other: Enhanced collaboration to promote patient participation | Arm Label: Usual Care Treatment; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care treatment | Intervention Type: OTHER; Name: Enhanced collaboration to promote patient participation; Assigned to Arm(s): Enhanced collaboration | Intervention Type: OTHER; Name: Usual Care treatment; Assigned to Arm(s): Usual Care Treatment

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of Subcutaneous CKD-11101 Versus Darbepoetin Alfa in Patients Who Had Renal Anemia Not on Dialysis
Brief Summary: The aim of this study was to compare and evaluate efficacy and safety of subcutaneous CKD-11101 versus Darbepoetin alfa in patients who have renal anemia not on dialysis.


Options:
A: Arm Label: MIRCERA; Type: EXPERIMENTAL; Interventions: Drug: methoxy polyethylene glycol-epoetin beta [Mircera] | Arm Label: Darbepoetin Alfa; Type: ACTIVE_COMPARATOR; Interventions: Drug: Darbepoetin alfa | Intervention Type: DRUG; Name: Darbepoetin alfa; Assigned to Arm(s): Darbepoetin Alfa | Intervention Type: DRUG; Name: methoxy polyethylene glycol-epoetin beta [Mircera]; Assigned to Arm(s): MIRCERA
B: Arm Label: CKD-11101(Darbepoetin alfa); Type: EXPERIMENTAL; Interventions: Biological: CKD-11101(Darbepoetin alfa) | Arm Label: NESP(Darbepoetin alfa); Type: ACTIVE_COMPARATOR; Interventions: Biological: NESP(Darbepoetin alfa) | Intervention Type: BIOLOGICAL; Name: CKD-11101(Darbepoetin alfa); Assigned to Arm(s): CKD-11101(Darbepoetin alfa) | Intervention Type: BIOLOGICAL; Name: NESP(Darbepoetin alfa); Assigned to Arm(s): NESP(Darbepoetin alfa)
C: Arm Label: C.E.R.A.; Type: ACTIVE_COMPARATOR; Interventions: Drug: comparison between darbepoetin alfa and C.E.R.A. and different administration intervals | Arm Label: Darbepoetin; Type: ACTIVE_COMPARATOR; Interventions: Drug: comparison between darbepoetin alfa and C.E.R.A. and different administration intervals | Intervention Type: DRUG; Name: comparison between darbepoetin alfa and C.E.R.A. and different administration intervals; Assigned to Arm(s): C.E.R.A., Darbepoetin
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: methoxy polyethylene glycol-epoetin beta [Mircera] | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: epoetin | Intervention Type: DRUG; Name: epoetin; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: methoxy polyethylene glycol-epoetin beta [Mircera]; Assigned to Arm(s): 1

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: TRAnexamic Acid for Preventing Postpartum Hemorrhage Following a Cesarean Delivery :a Multicenter Randomised, Double Blind Placebo Controlled Trial (TRAAP2)
Brief Summary: The aim is to assess the impact of tranexamic acid (TXA) for preventing postpartum hemorrhage (PPH) following a cesarean section (CS).


Options:
A: Arm Label: tranexamic acid 1 g (TA1); Type: EXPERIMENTAL; Interventions: Drug: tranexamic acid 1 g (TA1) | Arm Label: tranexamic acid 0.5 g (TA1/2); Type: EXPERIMENTAL; Interventions: Drug: tranexamic acid 0.5 g (TA1/2) | Arm Label: Saline Solution (TA0); Type: PLACEBO_COMPARATOR; Interventions: Drug: Saline Solution (TA0) | Arm Label: NH; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: tranexamic acid 1 g (TA1); Assigned to Arm(s): tranexamic acid 1 g (TA1) | Intervention Type: DRUG; Name: tranexamic acid 0.5 g (TA1/2); Assigned to Arm(s): tranexamic acid 0.5 g (TA1/2) | Intervention Type: DRUG; Name: Saline Solution (TA0); Assigned to Arm(s): Saline Solution (TA0)
B: Arm Label: TXA (1g); Type: EXPERIMENTAL; Interventions: Drug: TXA (1g) | Arm Label: Placebo (0.9% saline); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (0.9% saline) | Intervention Type: DRUG; Name: TXA (1g); Assigned to Arm(s): TXA (1g) | Intervention Type: DRUG; Name: Placebo (0.9% saline); Assigned to Arm(s): Placebo (0.9% saline)
C: Arm Label: Tranexamic acid; Type: EXPERIMENTAL; Interventions: Drug: Tranexamic Acid Injectable Solution | Arm Label: Chloride solution; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sodium Chloride 0.9% | Intervention Type: DRUG; Name: Tranexamic Acid Injectable Solution; Assigned to Arm(s): Tranexamic acid | Intervention Type: DRUG; Name: Sodium Chloride 0.9%; Assigned to Arm(s): Chloride solution
D: Arm Label: TXA; Type: EXPERIMENTAL; Interventions: Drug: Tranexamic Acid | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Tranexamic Acid; Assigned to Arm(s): TXA | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multicenter Prospective Clinical Trial to Evaluate Efficacy of Respiratory Rehabilitation Personalized Mobile Services for Respiratory Diseases
Brief Summary: This trial is multicenter prospective study to evaluate clinical efficacy of respiratory rehabilitation personalized mobile services for respiratory disease.


Options:
A: Arm Label: Fixed respiratory rehabilitation program(A); Type: EXPERIMENTAL; Interventions: Other: Fixed respiratory rehabilitation | Arm Label: Mixed respiratory rehabilitation program(B); Type: EXPERIMENTAL; Interventions: Other: Fixed respiratory rehabilitation, Other: Responsive respiratory rehabilitation | Arm Label: Control(C); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Fixed respiratory rehabilitation; Assigned to Arm(s): Fixed respiratory rehabilitation program(A), Mixed respiratory rehabilitation program(B) | Intervention Type: OTHER; Name: Responsive respiratory rehabilitation; Assigned to Arm(s): Mixed respiratory rehabilitation program(B)
B: Intervention Type: BEHAVIORAL; Name: Internet-based Dyspnea Self-Management Program; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Face-to-face Dyspnea Self-Management Program; Assigned to Arm(s): N/A
C: Arm Label: Intervention group "tele-rehabilitation"; Type: EXPERIMENTAL; Interventions: Combination Product: Tele Rehab | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Combination Product: Tele Rehab | Intervention Type: COMBINATION_PRODUCT; Name: Tele Rehab; Assigned to Arm(s): Control, Intervention group "tele-rehabilitation"
D: Arm Label: Targeted self-management barrier support; Type: EXPERIMENTAL; Interventions: Behavioral: Self-management barrier support | Arm Label: Guided COPD education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Basic COPD Education | Intervention Type: BEHAVIORAL; Name: Self-management barrier support; Assigned to Arm(s): Targeted self-management barrier support | Intervention Type: BEHAVIORAL; Name: Basic COPD Education; Assigned to Arm(s): Guided COPD education

Answer: A